IDEXX LABORATORIES INC /DE (IDXX) revenue & profit
IDEXX LABORATORIES INC /DE (IDXX): revenue $4.3B, net income $1.1B in 2025; latest quarter +9.7% year over year. From SEC filings.
$4.3BRevenue 2025
TickerIDXX (Nasdaq)
IndustryHealthcare · In Vitro & In Vivo Diagnostic Substances
Revenue 2025$4.3B
Net income 2025$1.1B
Net margin24.6%
Annual revenue growth+10.4%
Latest quarter (2026 Q2) · Revenue$1.2B
vs. same quarter last year+9.7%
Latest quarter · Net income$338.4M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $3.4B | $679.1M | |
| 2023 | $3.7B | $845M | |
| 2024 | $3.9B | $887.9M | |
| 2025 | $4.3B | $1.1B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.